Saroglitazar

CAS : 495399-09-2

Ref. 3D-VUA39909

Informations sur le produit

• Nom: Saroglitazar
• Marque: Biosynth
• Description: Saroglitazar is a drug that belongs to the class of peroxisome proliferator-activated receptor (PPAR) agonists. It has been shown to be an effective treatment for type 2 diabetes, and it is used to treat dyslipidemia and metabolic disorders. Saroglitazar has also been shown to have anti-inflammatory effects. Saroglitazar binds to PPAR receptors in the cell membrane, which leads to increased expression of lipoprotein lipase, a key enzyme in lipid metabolism. This effect results in an increase in the uptake of glucose from the blood into cells and improved insulin sensitivity. Saroglitazar has also been shown to activate Toll-like receptor 4 (TLR4), leading to increased expression of interleukin-10 (IL-10) and decreased production of tumor necrosis factor alpha (TNFα). This may be associated with its ability to inhibit HIV replication by downregulating viral transcriptional regulation.

Propriétés chimiques

• Masse moléculaire: 444.6 g/mol
• Formule: C₂₅H₂₄H₅NO₄S
• Degré de pureté: Min. 95%